Skip to main content
PLOS One logoLink to PLOS One
. 2023 Aug 15;18(8):e0289735. doi: 10.1371/journal.pone.0289735

Connective differences between patients with depression with and without ASD: A case-control study

Tomoki Kaneko 1,*, Toshinori Nakamura 2, Akiko Ryokawa 2, Shinsuke Washizuka 2, Yoshihiro Kitoh 3, Yasunari Fujinaga 1
Editor: Federico Giove4
PMCID: PMC10427005  PMID: 37582068

Abstract

Background

Researchers find it difficult to distinguish between depression with ASD (Depress-wASD) and without ASD (Depression) in adult patients. We aimed to clarify the differences in brain connectivity between patients with depression with ASD and without ASD.

Methods

From April 2017 to February 2019, 22 patients with suspected depression were admitted to the hospital for diagnosis or follow-up and met the inclusion criteria. The diagnosis was determined according to the Diagnostic and Statistical Manual of Mental Disorders-5 by skilled psychiatrists. The Hamilton Depression Rating Scale (HAM-D), Young Mania Raging Scale (YMRS), Mini-International Neuropsychiatric Interview, Parent-interview ASD Rating Scale-Text Revision (PARS-TR), and Autism-Spectrum Quotient-Japanese version (AQ-J) were used to assess the patients’ background and help with diagnosis. Resting-state functional magnetic resonance imaging (rs-fMRI) was performed using the 3-T-MRI system. rs-fMRI was processed using the CONN functional connectivity toolbox. Voxel-based morphometry was performed using structural images.

Results

No significant difference was observed between the Depress-wASD and Depression groups using the HAM-D, YMRS, AQ-J, Intelligence Quotient (IQ), and verbal IQ results. rs-fMRI for the Depress-wASD group indicated a positive connection between the salience network (SN) and right supramarginal gyrus (SMG) and a negative connection between the SN and hippocampus and para-hippocampus than that for the Depression group. No significant structural differences were observed between the groups.

Conclusions

We identified differences in the SN involving the SMG and hippocampal regions between the Depress-wASD and Depression groups.

Introduction

According to the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5), autism spectrum disorder (ASD) is classified as a neurodevelopmental disorder. It is defined as “an impairment in social communication” and “limited interest,” and these impairments appear in the first 2 years of life [1]. In a survey of 3,954 of 5,016 5-year-old children, Sato et al. reported on a crude ASD prevalence of 1.73% (95% confidence interval [CI] 1.37–2.10%) and a male-female ratio of 2.22: 1. The prevalence after statistically adjusting for the non-participating children was estimated to be 3.22% (95% CI 2.66–3.76%) [2].

Approximately 30% of young adults with ASD have co-occurring psychiatric disorders [3]. ASD affects intellectual ability in approximately 30% of the cases and poses a high risk of depression. Depression is observed in 19.8% of the patients with ASD, compared with that in only 6.0% of the healthy controls [4]. The risk of a depression diagnosis is reportedly higher in patients with ASD without intellectual disability than in those with ASD and intellectual disability [4]. In addition, no effective treatment exists for this condition, and these impairments supposedly continue throughout a patient’s lifetime. Thus, optimized life support is likely to exert a positive effect on the patients’ quality of life [5].

Patients with ASD have reported a high rate of depression in studies on ASD complications [6, 7]. A meta-analysis on anxiety and depression in adults with ASD reported 23% and 37% pooled estimation of current and lifetime prevalence of depressive disorder, respectively [8]. In comparison to pediatric patients with ASD who develop depression, some adult patients with ASD may be diagnosed with depression and later indicate ASD [9]. Adult ASD with depression is difficult to diagnose because a physician has limited specific information regarding a patient’s childhood [10]. The DSM-5, International Statistical Classification of Disease and Related Health Problems, Tenth Revision, and DSM-IV-TR are used to diagnose ASD in adults; nonetheless, they have different sensitivity and specificity [11]. The Autism-Spectrum Quotient (AQ), Parent-Interview ASD Rating Scale-Text Revision (PARS), and Wechsler Intelligence Test are screening instruments used to assess ASD in Japan [12, 13]. Even if the AQ score of the patient exceeds the cut-off (≥33 points), further evaluation is required by a skilled physician for ASD diagnosis. The PARS is an excellent indicator of sensitivity and specificity in ASD diagnosis in adults because it provides information on the natural developmental characteristics of children [13]. However, it requires a direct interview with the primary caregiver, which is difficult in the current situation with limited mobility and visitations.

Task-based functional magnetic resonance imaging (ts-fMRI) is used to assess morphological and functional abnormalities, comparing the characteristics of patients with ASD and those of healthy individuals [1416]. ASD has numerous comorbidities, and some cases are treated as depression, particularly when depression is in the foreground. This is because it is difficult to diagnose the underlying ASD. Resting-state fMRI (rs-fMRI) is a technique for recording slow-frequency fluctuations of brain activity and analyzing the connectivity of brain regions [17]. We aimed to clarify differences between networks in patients with depression with ASD (Depress-wASD) and those without ASD (Depression).

Materials and methods

Patients

We recruited 25 consecutive individuals who were suspected of having depression and who visited the Department of Psychiatry at Shinshu University Hospital (Nagano, Japan) for a diagnosis or follow-up between April 2017 and February 2019. Of them, 22 individuals met the following criteria:

  1. Age ≥20 years while providing consent

  2. Planned to be treated at our hospital

  3. Received sufficient explanation about this study and provided informed consent. If consent could not be obtained directly because of their medical condition (e.g., the inability to speak or write), it was obtained from a surrogate.

The patient’s medical condition was investigated by skilled psychiatrists. They determined the presence of any metal in the body that would contraindicate an MRI examination. They confirmed the patient’s free will to participate in the study and whether the patient could keep calm during the examination. Informed consent was obtained from each participant. We obtained consent for publication from each patient. All procedures were performed in accordance with relevant guidelines/regulations of the ethics committee of Shinshu University School of Medicine and the tenets of the Declaration of Helsinki.

We excluded three patients for the following reasons: incomplete data on fMRI (n = 1), incomplete psychological test result (n = 1), and left handedness (n = 1).

Diagnostic criteria and psychological examinations

Diagnosis was determined according to the DSM-5 by assessing the medical history and continuous observation of psychiatric symptoms by skilled psychiatrists. Because there were no physical criteria to diagnose these neurodevelopmental disorders, skilled psychiatrists used the following clinical information: depression severity rating according to the Hamilton Depression Rating Scale (HAM-D), manic severity rating according to the Young Mania Raging Scale (YMRS), The Mini-International Neuropsychiatric Interview (M. I. N. I.), Parent-interview ASD Rating Scale-Text Revision (PARS-TR), and AQ-Japanese version (AQ-J). In addition, clinical tests necessary for diagnosis and treatment were performed as needed. Finally, 8 out of 22 patients were diagnosed with Depress-wASD by the psychiatrists.

Neuroimaging acquisition

We used a 3-Tesla MRI system (Prisma system; Siemens, Erlangen, Germany) with a 64-channel head coil. Anatomical images were obtained using a three-dimensional T1-weighted Magnetization-Prepared Rapid-Gradient Echo sequence (repetition time [TR] = 1,900 ms, echo time [TE] = 2.9 ms, inversion time [TI] = 960 ms, and flip angle = 9°, 1 × 1 × 1-mm resolution). The acquisition time was 5 min 50 s. We performed rs-fMRI using a two-dimensional gradient echo-planar sequence (TR = 2,500 ms, TE = 30 ms, and flip angle = 80°), voxel size = 3.3 × 3.3 × 3.2 mm, and acquisition time = 10 min. The patients were instructed to remain awake and to look at one point. We adopted an auto-discarding system that scanned the first 10 volumes and discarded them to allow for magnetic field stabilization.

Resting-state functional MRI analysis

We used the CONN functional connectivity toolbox 18a (www.nitrc.org/projects/conn) in the MATLAB R2018a environment (Marth Works, USA).

Preprocessing

Functional and structural images were preprocessed using the default preprocessing CONN pipeline [18]. This preprocessing enabled us to rectify each patient’s blood oxygen level-dependent (BOLD) signal to the template coordinates (Figs 1 and 2).

Fig 1. The preprocessing flow chart.

Fig 1

Functional and structural images are normalized and segmented directory to the Montreal Neurological Institute (MNI) space. Before normalization to the MNI space, the functional images are corrected for slice timing and realigned to the reference, and outlier components are detected.

Fig 2. The preprocessing flow chart detailing the image information.

Fig 2

The block images depict the process and major output images for later statistical analyses.

  1. Functional direct preprocessing pipeline: First, we executed “slice timing correction.” A functional head volume image was obtained through inter-leaved acquisition. Subsequently, we fixed the slice timing, paying attention to prevent mixing of the multiple timing points with the following process. In the subsequent realignment and unwarping step, we realigned and unwrapped the functional images, estimating and correcting for subject motion. The centering step roughly corrected the functional images along the anterior-posterior commissure line. During outlier detection, potential outlier scans of framewise displacements >0.9 mm or BOLD signal changes >5 s.d. were detected and flagged as potential outliers. Throughout the process, functional images were normalized into the standard MNI space using SPM12 (Statistical Parametric Mapping) and were segmented into gray matter (GM), white matter (WM), and cerebral spinal fluid (CSF). Direct processing ensured that these images were normalized and segmented separately without any relation to structural preprocessing. Finally, they were smoothed with an 8-mm Gaussian kernel full with half maximum (FWHM) to increase the signal-to-noise (S/N) ratio.

  2. Furthermore, the structural images were normalized and segmented as functional processing using SPM unified segmentation and normalization procedures.

Denoising

To minimize the influence of artifactual factors on functional connectivity measures, we adopted a default denoising pipeline combining the two steps, namely, linear regression and temporal band-pass filtering.

  1. Linear regression involved the following steps: anatomical component-based noise correction procedure (aCompCor), noise components from the cerebral WM and cerebrospinal areas, estimating patient-motion parameters, identifying outlier scans or scrubbing, and first-order linear session effects.

  2. Temporal band-pass filtering and temporal frequencies <0.008 Hz or >0.09 Hz were removed from the BOLD signal to focus on slow-frequency fluctuations.

First- and second-level analysis

  1. First-level analysis: Region of interest (ROI)-to-ROI connectivity (RRC) matrices were estimated by characterizing the functional connectivity between each pair of regions among 164 HPC-ICA networks and Harvard-Oxford atlas ROIs [18, 19]. These RRC matrices represented the connectivity level of each pair of ROIs, and each element in a matrix was defined as the Fisher-transformed bivariate correlation coefficient between a pair of ROI BOLD time series [20].

  2. Second-level analysis: We compared the pairwise ROI-to-ROI connectivity strength values across the diagnostic groups (Depression with ASD vs. Depression without ASD (Depression)) with adjustment for the age, sex, YMRS, IQ, verbal IQ, AQ-J, HAM-D, and PARS scores as the covariates. Second-level analyses were performed using a General Linear Model (GLM) [20]. Connection-level hypotheses were evaluated using multivariate parametric statistics with random-effects across participants and sample covariance estimation across multiple measurements. We drew inferences at the level of individual clusters (groups of similar connections). Cluster-level inferences were based on parametric statistics within and between each pair of networks (Functional Network Connectivity), with the networks identified using a complete-linkage hierarchical clustering procedure [21, 22] based on the ROI-to-ROI anatomical proximity and functional similarity metrics [20]. The results were thresholded using a combination of a p-value <0.05 connection-level threshold and a familywise corrected p-FDR <0.05 cluster-level threshold [23] (Fig 3).

Fig 3. The preprocessing flow chart.

Fig 3

Structural analysis

Voxel-based morphometry

We used SPM12 to estimate the differences between Depress-wASD and Depression. Preprocessed structural images were smoothed with a 6-mm Gaussian kernel of FWHM to increase the S/N ratio.

Post-processed structural images were divided into two groups as follows: Depress-wASD and Depression. First, we constructed a design matrix to adopt the GLM [20] and to identify regions significantly related to the differences between the groups. Furthermore, we performed an estimation to validate the independently distributed residuals. Finally, we performed the two-sample t-test using the standard parametric procedure to test the hypothesis [24].

This study was approved by the ethics committee of Shinshu University School of Medicine (3612). Written informed consent was obtained from all participants or their parents.

Results

Demographics

No significant difference was observed between the Depress-wASD and Depression groups in terms of the sex, age, HAM-D, YMRS, AQ, PARS, IQ, and verbal IQ (Table 1). All participants remained calm during the examination. No data were excluded because of severe motion artifacts or other artifacts.

Table 1. Demographics.

Non-ASD ASD p-value
n 14 8
Male:female 6:8 5:3 0.661)
Age median [min, max] 39 [22, 52] 25.5 [21, 41] 0,062)
HAM-D median [min, max] 17 [8, 28] 16.5 [9, 29] 0.892)
YMRS median [min, max] 0 [0, 5] 0 [0, 6] 0.682)
AQ median [min, max] 25 [10, 40] 27 [15, 39] 0.912)
PARS median [min, max] 6.5 [3, 23] 12.5 [6, 33] 0.132)
IQ median [min, max] 96 [76, 114] 97 [54, 112] 0.852)
Verbal IQ median [min, max] 98.5 [75, 207] 101.1 [63, 104] 0.482)

HAM-D, Hamilton Depression Rating Scale; YMRS, Young Mania Rating Scale; AQ, Autism-Spectrum Quotient; PARS, Parent-interview ASD Rating Scale; and IQ, Intelligence Quotient. 1) Fisher’s exact test; 2) Mann–Whitney U test

Depress-wASD versus depression

In this analysis, the left salience network (SN) displayed increased connectivity to the right supramarginal gyrus (SMG) (p-FDR<0.04*) and decreased connectivity to the left hippocampus (p-FDR<0.02*) and para-hippocampus (p-FDR<0.02*). However, no significant increase or decrease was observed in the activity of each seed (Fig 4, Table 2).

Fig 4. Increased connectivity in the red lines and decreased connectivity in the blue lines.

Fig 4

The purple block depicts the seed point with statistics of the strength of the seed activity. Each colored block indicates the increased and decreased strength of connectivity with statistics (T- and p-values), respectively. Increased connection is observed between the salience network (SN) and the right posterior SMG. Decreased connection is observed between the SN and the left hippocampus and para-hippocampus gyrus. There is no significant increase/decrease in each seed.

Table 2. Functional connectivity between patients with depression with and without ASD.

Statistic p-FDR
Seed Networks. Salience. RPFC F = 5.49
Intensity = 13.45
Size = 3
-
• Hippocampus (left) T = -4.73 0.02
• Posterior para-hippocampus (left) T = -4.67 0.02
• Posterior supramarginal gyrus (right) T = 4.05 0.04

FDR, false discovery rate, RPFC, rostral prefrontal cortex. The statistical results can be thresholded using a combination of connection-level threshold; F-test on the network-based statistics.

Volumetric findings

We observed no significant difference between the Depress-wASD and Depression groups.

Discussion

We performed an ROI-to-ROI analysis to investigate the difference in connectivity between Depress-wASD and Depression groups. We hypothesized that the DMN of the Depression group, termed as characteristic connectivity, would demonstrate higher connectivity than that of the Depress-wASD group; nonetheless, no significant difference was observed around the DMN. In contrast, the SN demonstrated increased connectivity to the right SMG and decreased connectivity to the left hippocampus and para-hippocampus.

In this study, the numbers of men and women were equal in both the groups. We identified relatively more men with ASD and relatively fewer women with depression; however, there was no statistically significant difference in sex distribution. Generally, ASD is >4 times more common among men than among women, and depression is twice as common among women [2527]. The equal number of men and women in this study was in line to that in a previous study because of the opposite sex distribution between ASD and depression [2527]. However, our sample size was relatively small to analyze sex differences. Researchers should consider other psychiatric disorders upon identifying no sex differences in the population presenting with depression.

Depress-wASD versus depression

The Depress-wASD group displayed increased connectivity between the SN and right SMG and decreased connectivity between the SN and hippocampal regions. No significant difference was observed in the verbal IQ between the groups.

The SN refers to a series of brain networks comprising the anterior cingulate cortex, anterior insula, and orbitofrontal cortex; it contributes to numerous complex brain functions, including communication, social behavior, and self-awareness by integrating sensory, emotional, and cognitive information [28, 29]. rs-fMRI for 17 children with ASD displayed greater connectivity between the SN regions (SMG to rostral prefrontal cortex [rPFC]) and lower verbal IQ than those in control patients [30]. In contrast, in typically developing patients, the functional connectivity between the SN and medial PFC decreased with age; however, no significant change was observed in the patients with ASD [31], consistent with our findings. Within the SN, the rPFC supports a cognitive system [32, 33]. The medial area of the PFC supports processes related to stimulus-oriented attending, i.e., the behavior required to concentrate on current sensory input. By contrast, stimulus-independent attending is the mental processing that accompanies self-generated or self-maintained thoughts [32]. Moreover, multitasking is significantly impaired in patients with rPFC lesions, despite no significant impairment in remembering the task rules [34]. Reports of high connectivity in the SN-rSMG in children with ASD indicate residual childhood connectivity or delayed development.

We discuss the high connectivity between the SN and the right SMG and the low connectivity between the SN and memory areas from brain function development during language acquisition in the Japanese. Japanese infants aged from 4 to 5 years can segment words using voice input by mora units [35]. When they begin to learn the letters, they connect a word with phonology. In the initial stage of character acquisition, each character is converted phonologically and read sequentially; however, once the reading becomes proficient, meaning processing is possible only with character form information of the word without undergoing phonological conversion [36]. In an fMRI study comprising 37 right-handed adults, 95% of them demonstrated dominant speech and language function in the left hemisphere [37]. Hartwigen et al. mentioned that both the left and right SMGs were required for phonological decisions [38]. Our present results suggested that the network connectivity persists in adult patients with depression and ASD, and this persistence disturbs the functional differentiation that should be obtained by the functional localization observed in healthy adults. Moreover, this network demonstrated decreased connectivity to the hippocampus, which may lead to the disruption of phonological decisions. Our patients demonstrated normal verbal IQ; however, those with ASD may have developed depression because they managed to adapt to the environment, despite a disrupted phonological network.

Reports on ASD in children indicate that depression assessment is difficult because of nonspecific symptoms and overlapping phenotypic systems in ASD [39]. In a population-based birth cohort study, Maja et al. reported that approximately half of the participants had normal or high IQ, which increases the risk of not being diagnosed with ASD [40].

ASD is a spectrum of disorders, and our results capture only one aspect. However, changes in the functional brain connectivity may be a risk factor for the development of depression even if the patients appear to be well adjusted. Screening at an early stage may be necessary to enhance the effectiveness of therapeutic interventions.

We performed VBM using SPM12 to compare the structural differences between the Depress-wASD and Depression groups. Our results demonstrated no significant structural differences between these groups, despite previous reports on variable structural abnormality in patients with ASD presenting with increased or decreased volumes in the specific areas of the brain [4144]. In previous studies, patients with ASD had varied age and clinical background (comorbidity, educational, and genetic profiles). Ecker et al. mentioned that patients with ASD had increased GM volume in the anterior temporal and dorsolateral prefrontal regions and decreased volume in the occipital and medial parietal regions, compared with healthy controls, despite no significant difference in the whole brain volume [41]. In the present study, patients with ASD demonstrated no structural differences from those with depression. However, patients with depression display significant volume reductions than healthy controls, particularly in the hippocampus and amygdala [45, 46]. The differences in morphological alterations in each study could be attributed to variances in the clinical background. Therefore, our results indicated some structural abnormality in patients with ASD that should be reexamined in healthy controls.

MRI of Depress-wASD

rs-fMRI requires a longer scanning time to obtain more information and achieve highly reproducible connectivity, compared with other routine sequences. Therefore, patients are instructed to remain awake and keep calm during the examination [47]. In this study, the patients did not present with ASD symptoms and were suspected of having depression. Despite including the patients with low IQs, they understood the explanation on the MRI procedure and were able to keep calm during the examination. Furthermore, we considered the age of the patients to account for the lack of severe movements or complaints. Our patients only displayed a small proportion of the characteristics of adult-onset ASD.

Limitations

The limitations of this consecutive case series study include a small sample size. Accordingly, comparison between the ASD groups and the age-matched control group with a larger sample size is needed to confirm our findings. We intend to investigate the phonological function regarding language processing between the Depress-wASD group and age-matched normal participants using task-based fMRI.

Conclusions

The Depress-wASD and Depression groups demonstrated differences in the SN involving the SMG and hippocampal regions. Our findings suggest that an immature phonological network could be one of the potential causes of depression in adult ASD.

Supporting information

S1 File. The signal-to-noise ratio of the each preprocessing process.

(PDF)

Abbreviations

ASD

autism spectrum disorder

AQ-J

Autism-Spectrum Quotient-Japanese version

CI

confidence interval

CSF

cerebrospinal fluid

DMN

default mode network

DSM-5

Diagnostic and Statistical Manual of Mental Disorders-5

FDR

false discovery rate

HAM-D

Hamilton Depression Rating Scale

GM

gray matter

M.I.N.I

Mini-International Neuropsychiatric Interview

PARS

Parent-interview ASD Rating Scale-Text Revision

PFC

prefrontal cortex

ROI

region of interest

SMG

supramarginal gyrus

SN

salience network

TE

echo time

TI

inversion time

TR

repetition time

ts-fMRI

task-based functional magnetic resonance imaging

WM

white matter

YMRS

Young Mania Raging Scale

Data Availability

Data cannot be shared publicly because of not getting consent about the data publicity. In addition, when we obtained consent, the consent form did not contain the clause for public sharing. After consultation with the Ethics Committee of Shinshu University Hospital, the data are available to researchers who meet the criteria for access to confidential data from the responsible party listed below. The image data for this study are stored on the data server of the Division of Radiology, Shinshu University Hospital. The person responsible for managing the image data used in this study is Yasuo Adachi. He is a radiological technologist at the section chief of the MRI in the division of radiology in the shinshu-university hospital. The e-mail address for contacting Yasuo Adachi is yadachi@shinshu-u.ac.jp.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Leyfer OT, Folstein SE, Bacalman S, Davis NO, Dinh E, Morgan J, et al. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord. 2006;36: 849–861. doi: 10.1007/s10803-006-0123-0 [DOI] [PubMed] [Google Scholar]
  • 2.Saito M, Hirota T, Sakamoto Y, Adachi M, Takahashi M, Osato-Kaneda A, et al. Prevalence and cumulative incidence of autism spectrum disorders and the patterns of co-occurring neurodevelopmental disorders in a total population sample of 5-year-old children. Mol Autism. 2020;11: 35. doi: 10.1186/s13229-020-00342-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mosner MG, Kinard JL, Shah JS, McWeeny S, Greene RK, Lowery SC, et al. Rates of co-occurring psychiatric disorders in autism spectrum disorder using the mini international neuropsychiatric interview. J Autism Dev Disord. 2019;49: 3819–3832. doi: 10.1007/s10803-019-04090-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rai D, Heuvelman H, Dalman C, Culpin I, Lundberg M, Carpenter P, et al. Association between autism spectrum disorders with or without intellectual disability and depression in young adulthood. JAMA Netw Open. 2018;1: e181465. doi: 10.1001/jamanetworkopen.2018.1465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Matson JL, Cervantes PE, Peters WJ. Autism spectrum disorders: management over the lifespan. Expert Rev Neurother. 2016;16: 1301–1310. doi: 10.1080/14737175.2016.1203255 [DOI] [PubMed] [Google Scholar]
  • 6.Ghaziuddin M, Ghaziuddin N, Greden J. Depression in persons with autism: implications for research and clinical care. J Autism Dev Disord. 2002;32: 299–306. doi: 10.1023/a:1016330802348 [DOI] [PubMed] [Google Scholar]
  • 7.Matson JL, Cervantes PE. Commonly studied comorbid psychopathologies among persons with autism spectrum disorder. Res Dev Disabil. 2014;35: 952–962. doi: 10.1016/j.ridd.2014.02.012 [DOI] [PubMed] [Google Scholar]
  • 8.Hollocks MJ, Lerh JW, Magiati I, Meiser-Stedman R, Brugha TS. Anxiety and depression in adults with autism spectrum disorder: a systematic review and meta-analysis. Psychol Med. 2019;49: 559–572. doi: 10.1017/S0033291718002283 [DOI] [PubMed] [Google Scholar]
  • 9.Takara K, Kondo T. Autism spectrum disorder among first-visit depressed adult patients: diagnostic clues from backgrounds and past history. Gen Hosp Psychiatry. 2014;36: 737–742. doi: 10.1016/j.genhosppsych.2014.08.004 [DOI] [PubMed] [Google Scholar]
  • 10.Chandrasekhar T, Sikich L. Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespan. Dialogues Clin Neurosci. 2015;17: 219–227. doi: 10.31887/DCNS.2015.17.2/tchandrasekhar [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Wilson CE, Gillan N, Spain D, Robertson D, Roberts G, Murphy CM, et al. Comparison of ICD-10R, DSM-IV-TR and DSM-5 in an adult autism spectrum disorder diagnostic clinic. J Autism Dev Disord. 2013;43: 2515–2525. doi: 10.1007/s10803-013-1799-6 [DOI] [PubMed] [Google Scholar]
  • 12.Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The Autism-Spectrum Quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31: 5–17. doi: 10.1023/a:1005653411471 [DOI] [PubMed] [Google Scholar]
  • 13.Kitaoka T, Morimoto M, Hashimoto T, Tsuda Y, Nakatsu T, Kyotani S. Evaluation of the efficacy of drug treatment based on measurement of the oxidative stress, using reactive oxygen metabolites and biological antioxidant potential, in children with autism spectrum disorder and attention deficit hyperactivity disorder. J Pharm Health Care Sci. 2020;6: 8. doi: 10.1186/s40780-020-00164-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bookheimer SY, Wang AT, Scott A, Sigman M, Dapretto M. Frontal contributions to face processing differences in autism: evidence from fMRI of inverted face processing. J Int Neuropsychol Soc. 2008;14: 922–932. doi: 10.1017/S135561770808140X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gilbert SJ, Bird G, Brindley R, Frith CD, Burgess PW. Atypical recruitment of medial prefrontal cortex in autism spectrum disorders: an fMRI study of two executive function tasks. Neuropsychologia. 2008;46: 2281–2291. doi: 10.1016/j.neuropsychologia.2008.03.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Knaus TA, Silver AM, Lindgren KA, Hadjikhani N, Tager-Flusberg H. fMRI activation during a language task in adolescents with ASD. J Int Neuropsychol Soc. 2008;14: 967–979. doi: 10.1017/S1355617708081216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A. 2003;100: 253–258. doi: 10.1073/pnas.0135058100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2: 125–141. doi: 10.1089/brain.2012.0073 [DOI] [PubMed] [Google Scholar]
  • 19.Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31: 968–980. doi: 10.1016/j.neuroimage.2006.01.021 [DOI] [PubMed] [Google Scholar]
  • 20.Nieto-Castanon A. Handbook of fcMRI methods in CONN 2020. [Google Scholar]
  • 21.Jafri MJ, Pearlson GD, Stevens M, Calhoun VD. A method for functional network connectivity among spatially independent resting-state components in schizophrenia. Neuroimage. 2008;39: 1666–1681. doi: 10.1016/j.neuroimage.2007.11.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sørensen T. A method of establishing groups of equal amplitude in plant sociology based on similarity of species and its application to analyses of the vegetation on Danish commons. Biol Skrifter / Kongelige Danske Videnskabernes Selskab. 1948;5: 1–34. [Google Scholar]
  • 23.Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodol). 1995;57: 289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x [DOI] [Google Scholar]
  • 24.Ashburner J, Friston KJ. Voxel-based morphometry—the methods. Neuroimage. 2000;11: 805–821. doi: 10.1006/nimg.2000.0582 [DOI] [PubMed] [Google Scholar]
  • 25.Maenner MJ, Shaw KA, Bakian AV, Bilder DA, Durkin MS, Esler A, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018. MMWR Surveill Summ. 2021;70: 1–16. doi: 10.15585/mmwr.ss7011a1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dietz PM, Rose CE, McArthur D, Maenner M. National and state estimates of adults with autism spectrum disorder. J Autism Dev Disord. 2020;50: 4258–4266. doi: 10.1007/s10803-020-04494-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Salk RH, Hyde JS, Abramson LY. Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms. Psychol Bull. 2017;143: 783–822. doi: 10.1037/bul0000102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Brain Mapping MV, Toga AW, editor. Elsevier; 2015. [Google Scholar]
  • 29.Ueno D, Matsuoka T, Kato Y, Ayani N, Maeda S, Takeda M, et al. Individual differences in interoceptive accuracy are correlated with salience network connectivity in older adults. Front Aging Neurosci. 2020;12: 592002. doi: 10.3389/fnagi.2020.592002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Margolis AE, Pagliaccio D, Thomas L, Banker S, Marsh R. Salience network connectivity and social processing in children with nonverbal learning disability or autism spectrum disorder. Neuropsychology. 2019;33: 135–143. doi: 10.1037/neu0000494 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lawrence KE, Hernandez LM, Bookheimer SY, Dapretto M. Atypical longitudinal development of functional connectivity in adolescents with autism spectrum disorder. Autism Res. 2019;12: 53–65. doi: 10.1002/aur.1971 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Burgess PW, Gilbert SJ, Dumontheil I. Function and localization within rostral prefrontal cortex (area 10). Philos Trans R Soc Lond B Biol Sci. 2007;362: 887–899. doi: 10.1098/rstb.2007.2095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Koechlin E, Ody C, Kouneiher F. The architecture of cognitive control in the human prefrontal cortex. Science. 2003;302: 1181–1185. doi: 10.1126/science.1088545 [DOI] [PubMed] [Google Scholar]
  • 34.Burgess PW, Veitch E, de Lacy Costello A, Shallice T. The cognitive and neuroanatomical correlates of multitasking. Neuropsychologia. 2000;38: 848–863. doi: 10.1016/s0028-3932(99)00134-7 [DOI] [PubMed] [Google Scholar]
  • 35.Ito T, Tokushuhaku-ni taisuru meta gengo chishiki [The development of metalinguistic awareness of mora-phonemes in Japanese young children] (in Japanese). The Japan Society of Logopedics and Phoniatrics. 1997;38: 196–203. doi: 10.5112/jjlp.38.196 [DOI] [Google Scholar]
  • 36.Murakami I. Illustrated lecture-cognitive neuroscience (in Japanese): ohumu; 2010. [Google Scholar]
  • 37.Vikingstad EM, George KP, Johnson AF, Cao Y. Cortical language lateralization in right handed normal subjects using functional magnetic resonance imaging. J Neurol Sci. 2000;175: 17–27. doi: 10.1016/s0022-510x(00)00269-0 [DOI] [PubMed] [Google Scholar]
  • 38.Hartwigsen G, Baumgaertner A, Price CJ, Koehnke M, Ulmer S, Siebner HR. Phonological decisions require both the left and right supramarginal gyri. Proc Natl Acad Sci U S A. 2010;107: 16494–16499. doi: 10.1073/pnas.1008121107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Magnuson KM, Constantino JN. Characterization of depression in children with autism spectrum disorders. J Dev Behav Pediatr. 2011;32: 332–340. doi: 10.1097/DBP.0b013e318213f56c [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Katusic MZ, Myers SM, Weaver AL, Voigt RG. IQ in autism spectrum disorder: A population-based birth cohort study. Pediatrics. 2021;148: e2020049899. doi: 10.1542/peds.2020-049899 [DOI] [PubMed] [Google Scholar]
  • 41.Ecker C, Suckling J, Deoni SC, Lombardo MV, Bullmore ET, Baron-Cohen S, et al. Brain anatomy and its relationship to behavior in adults with autism spectrum disorder: a multicenter magnetic resonance imaging study. Arch Gen Psychiatry. 2012;69: 195–209. doi: 10.1001/archgenpsychiatry.2011.1251 [DOI] [PubMed] [Google Scholar]
  • 42.Owen JP, Bukshpun P, Pojman N, Thieu T, Chen Q, Lee J, et al. Brain MR imaging findings and associated outcomes in carriers of the reciprocal copy number variation at 16p11.2. Radiology. 2018;286: 217–226. doi: 10.1148/radiol.2017162934 [DOI] [PubMed] [Google Scholar]
  • 43.Noppari T, Sun L, Lukkarinen L, Putkinen V, Tani P, Lindberg N, et al. Brain structural alterations in autism and criminal psychopathy. NeuroImage Clin. 2022;35: 103116. doi: 10.1016/j.nicl.2022.103116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Via E, Radua J, Cardoner N, Happé F, Mataix-Cols D. Meta-analysis of gray matter abnormalities in autism spectrum disorder: should Asperger disorder be subsumed under a broader umbrella of autistic spectrum disorder? Arch Gen Psychiatry. 2011;68: 409–418. doi: 10.1001/archgenpsychiatry.2011.27 [DOI] [PubMed] [Google Scholar]
  • 45.Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp. 2009;30: 3719–3735. doi: 10.1002/hbm.20801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Arnone D, Job D, Selvaraj S, Abe O, Amico F, Cheng Y, et al. Computational meta-analysis of statistical parametric maps in major depression. Hum Brain Mapp. 2016;37: 1393–1404. doi: 10.1002/hbm.23108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Stogiannos N, Carlier S, Harvey-Lloyd JM, Brammer A, Nugent B, Cleaver K, et al. A systematic review of person-centred adjustments to facilitate magnetic resonance imaging for autistic patients without the use of sedation or anaesthesia. Autism. 2022;26: 782–797. doi: 10.1177/13623613211065542 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Jerritta Selvaraj

23 Sep 2022

PONE-D-22-14224Connective differences between autism spectrum disorder with depressive state and depression: case-control study.PLOS ONE

Dear Dr. Kaneko,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 07 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jerritta Selvaraj

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please describe in your methods section how capacity to provide consent was determined for the participants in this study. Please also state whether your ethics committee or IRB approved this consent procedure. If you did not assess capacity to consent please briefly outline why this was not necessary in this case.

Please also note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

3. Thank you for stating the following financial disclosure:

"No financial disclosure."

At this time, please address the following queries:

a)        Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b)        State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c)        If any authors received a salary from any of your funders, please state which authors and which funders.

d)        If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: a) the manuscript can provide further more information regarding the Autism Spectrum Disorder with depressive state and with depression for clarity of the topic and need to do the research. the reviewer wasn't able to capture the clear information regarding the ASD with depressive state and depression. it is understood from science that brain structural differences are seen in persons with ASD and without ASD and this needs to correlated as the study is done with the help of MRI.

b) as far as ASD condition is concerned, the males are more affected by ASD than females. the article should have pronounced sex differences, since females experience twice as much depression as males.

c) As a Rehabilitation Professional- Educationists , Psychologists look for the behavioural output of the subjects. it is not revealed in the study and the reviewer has limitations in further reviewing the manuscript.

Reviewer #2: Title: Connective differences between autism spectrum disorder with depressive state and depression: case-control study

1. How the authors describe the resting state of ASD individuals? Since the people with ASD has different comorbidities and exhibit restlessness in some individuals,

2. Authors pls check for the abbreviations for eg:-DSM 5 is repeated .It can be defined at initial stage itself.

3. Methodology can be given in detail using a block diagram or pictorial representation

4. Technical information is lagging in the manuscript. Such as pre-processed images its metrics and equation related to filtering

5. There is no proof for pre-processing of the functional and structural images and the metrics can be specified.

6. Did the ASD participants were assisted by their caregivers?

7. ASD individuals don’t adjust to social setting. Pls mention the challenges in recording rs fMRI

8. Figure 1 and 2 can be cited with more information.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: B. Anandhi

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Connective Diff-Comments.docx

PLoS One. 2023 Aug 15;18(8):e0289735. doi: 10.1371/journal.pone.0289735.r002

Author response to Decision Letter 0


5 Mar 2023

Reviewer #1: a) the manuscript can provide further more information regarding the Autism Spectrum Disorder with depressive state and with depression for clarity of the topic and need to do the research. the reviewer wasn't able to capture the clear information regarding the ASD with depressive state and depression. it is understood from science that brain structural differences are seen in persons with ASD and without ASD and this needs to correlated as the study is done with the help of MRI.

Response: We thank the reviewer for this comment. In response, we have performed voxel-based morphometry and added the following sentences to the Methods, Results, and Discussion sections.

Methods

“Structural analysis

Voxel-based Morphometry

We used SPM12 to estimate differences between depression and ASD with depressive state. Preprocessed structural images were smoothed with a 6-mm Gaussian kernel of FWHM to increase the S/N ratio.

Post-processed structural images were divided into two groups: ASD with depressive state and depression. First, we constructed a design matrix to adopt the general linear model (GLM) and identify regions significantly related to the differences between the two groups. We also performed estimation to validate the independently distributed residuals. Finally, we analyzed the two-sample t-test using the standard parametric procedure to test the hypothesis.[21]”

Results

“Volumetric findings

There was no significant difference between ASD with depressive state and depression.”

Discussion

“We performed voxel-based morphometry using SPM12 to compare the structural differences between ASD and depression.[21] Our results showed no significant structural differences between these two groups, although previous studies demonstrated variable structural abnormality in ASD subjects presenting with increased and decreased volumes in specific areas of the brain.[36-39] ASD subjects in previous studies varied in both age and clinical background (comorbidity, educational and genetic profiles). Compared with healthy controls adult ASD subjects, Ecker et al showed that adult ASD subjects had increased gray matter volume in the anterior temporal and dorsolateral prefrontal regions and decreased volume in the occipital and medial parietal regions, despite there being no significant difference in whole brain volume.[36] In the present study, ASD subjects showed no structural differences compared to subjects with depression. However, subjects with depression were known to display significant volume reductions compared to healthy controls, especially in the hippocampus and amygdala.[40-41] We assumed that the differences in morphological alterations in each study could be due to differences in clinical background. Therefore, our results indicated some structural abnormality in ASD subjects that should be reexamined in healthy controls.”

b) as far as ASD condition is concerned, the males are more affected by ASD than females. the article should have pronounced sex differences, since females experience twice as much depression as males.

Response: We thank the reviewer for this comment. We added following paragraphs in the Discussion section.

“In this study, the numbers of male and female subjects were equal in both the groups. Although there were slightly more male subjects with ASD and slightly fewer male subjects with depression, there was no statistically significant difference in gender distribution. In general, ASD is more than 4 times more common among males than among females, and depression is twice as common among females.[22-24] The equal number of males and females in this study was considered to match that in a previous study because of the opposite gender distribution between ASD and depression. However, the sample size in this study was too small to analyze gender differences. In the case that no gender differences were found in the population presenting with depression, other psychiatric disorders may need to be considered.”

c) As a Rehabilitation Professional-Educationists, Psychologists look for the behavioural output of the subjects. it is not revealed in the study and the reviewer has limitations in further reviewing the manuscript.

Response: We thank the reviewer for this comment. At our institution, patients referred from other institutions are examined, psychologically tested, and diagnosed clinically by an experienced psychiatrist. In this study, patients showed symptoms of depressive state, as shown in the inclusion criteria. However, subsequent physical examination and psychological testing revealed that the depressive state was associated with ASD rather than depression. Many patients received rehabilitation and treatment at the referral institution after the diagnosis was made. It was therefore difficult to consider outputs in more detail. We would appreciate the reviewer’s understanding on this matter.

Reviewer #2: Title: Connective differences between autism spectrum disorder with depressive state and depression: case-control study

1. How the authors describe the resting state of ASD individuals? Since the people with ASD has different comorbidities and exhibit restlessness in some individuals,

6. Did the ASD participants were assisted by their caregivers?

7. ASD individuals don’t adjust to social setting. Pls mention the challenges in recording rs fMRI

Response: We thank the reviewer for this comment. As pointed out, MRI examinations are considered difficult for patients with ASD, ADHD, and PDD, and ASD was reviewed. All participants in this valuable review were under 20 years of age, and most were children around 10 years of age. In contrast, our target patients were aged over 20 years and were willing to participate in this MRI study. In addition, he presented to the hospital in a depressed state, which is also considered to be the reason why there was no interruption due to movement during the examination and no deterioration of the image. All patients did not require caregiver attendance. However, as the reviewer pointed out, testing is expected to be difficult in general; we would therefore like to state in the Discussion section that the subject in this case was biased toward ASD who showed depressive state. We have revised the relevant paragraphs in Methods and Discussion sections according to these comments.

2. Authors pls check for the abbreviations for eg:-DSM 5 is repeated .It can be defined at initial stage itself.

Response: We thank the reviewer for this comment. We have modified the manuscript accordingly.

3. Methodology can be given in detail using a block diagram or pictorial representation

4. Technical information is lagging in the manuscript. Such as pre-processed images its metrics and equation related to filtering

5. There is no proof for pre-processing of the functional and structural images and the metrics can be specified.

Response: We thank the reviewer pointing this out. We added details on preprocessing accordingly. In addition, we created a block diagram explaining the processing method conducted in our study. Regarding the metrics, we did not add a corresponding diagram and explanation because they are described on the relevant web page.

8. Figure 1 and 2 can be cited with more information.

Response: We thank the reviewer for this comment. We have inserted the necessary citations in the figures accordingly.

Attachment

Submitted filename: revise_comment_to_reviewer_revise.docx

Decision Letter 1

Federico Giove

15 May 2023

PONE-D-22-14224R1Connective differences between autism spectrum disorder with depressive state and depression: case-control study.PLOS ONE

Dear Dr. Kaneko,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Reviewer #2 raised a number of further issues. Authors are encouraged to evaluate if amending the manuscript according to reviewer suggestions. Please include a rebuttal letter detailing which concerns have been addressed (and how), and which concerns have not been addressed (and why). Note that I'm not implying that all the concerns must be addressed. I'll take a final decision without further reviewers involvement.

Please submit your revised manuscript by Jun 29 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Federico Giove, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Dear Authors,

1.Authors pls expalin what is the dfifference between depressive state and depression.? Does the authors trying to find out mild , moderate or severe level of depression?

2.The authors have mentioned the preprocessing methods such as slicing, band pass filtering, smoothing and normalization but there is axial information of the filtered image , sliced image or normalized image ?Probably you can tabulate the results of each step and its S/N ratios achieved.

3.Though you use CONN connectivity tool box , need to mention the actual analysis between depressive state and depression this analysis. Pls give the raw image of Depression and Depressive state image

4 Authors claim that the statistical analysis by performing the F test, has right supramarginal gyrus (SMG) (p-FDR < 0.04*) and decreased connectivity to the left hippocampus (p-FDR < 0.02*) and para-hippocampus (p-FDR < 0.02*). What tool is used for this test ?.What are the hypothesis? Pls mention the Mean , STD from the statistical analysis.

5.Pls check the entire manusript for phraseaology, grammar ,and the connectivity between each section.

6.Improve the discussion section

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Dr.B.Anandhi

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Federico Giove

12 Jul 2023

PONE-D-22-14224R2Connective differences between patients with depression with and without ASD : a case-control studyPLOS ONE

Dear Dr. Kaneko,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript is fine, it can be accepted from a scientific standpoint. The data access policy stated in the manuscript is not acceptable. Authors must report in the article text the same policy declared in the forms, and in particular name and email of the person to be contacted to get access to the data. Please note that, even after including these details in the manuscript, the policy of your institution is too restrictive and incompatible with open data principles. For the future, if authors plan to submit to journals that require open data, ethical consent and local policies must be amended to allow unconditional sharing of anonymized data.

Please submit your revised manuscript by Aug 26 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Federico Giove, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Aug 15;18(8):e0289735. doi: 10.1371/journal.pone.0289735.r006

Author response to Decision Letter 2


22 Jul 2023

Journal Requirements:

1. The manuscript is fine, it can be accepted from a scientific standpoint.

The data access policy stated in the manuscript is not acceptable. Authors must report in the article text the same policy declared in the forms, and in particular name and email of the person to be contacted to get access to the data.

Response: Thank you for reviewing my manuscript.

We have changed our data access policy in the manuscript to be fit in the form.

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response: We have added "doi" to the No. 35 reference. In addition, we changed the style of No. 36 to that of the Book.

There were no comment from reviewer. So, we have submitted a revised version of the paper we submitted on July 9.

Attachment

Submitted filename: reply_to_author_wo_ja_0717.docx

Decision Letter 3

Federico Giove

26 Jul 2023

Connective differences between patients with depression with and without ASD : a case-control study

PONE-D-22-14224R3

Dear Dr. Kaneko,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Federico Giove, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Federico Giove

3 Aug 2023

PONE-D-22-14224R3

Connective differences between patients with depression with and without ASD : a case-control study

Dear Dr. Kaneko:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Federico Giove

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. The signal-to-noise ratio of the each preprocessing process.

    (PDF)

    Attachment

    Submitted filename: Connective Diff-Comments.docx

    Attachment

    Submitted filename: revise_comment_to_reviewer_revise.docx

    Attachment

    Submitted filename: reply_to_author__wo_ja.docx

    Attachment

    Submitted filename: reply_to_author_wo_ja_0717.docx

    Data Availability Statement

    Data cannot be shared publicly because of not getting consent about the data publicity. In addition, when we obtained consent, the consent form did not contain the clause for public sharing. After consultation with the Ethics Committee of Shinshu University Hospital, the data are available to researchers who meet the criteria for access to confidential data from the responsible party listed below. The image data for this study are stored on the data server of the Division of Radiology, Shinshu University Hospital. The person responsible for managing the image data used in this study is Yasuo Adachi. He is a radiological technologist at the section chief of the MRI in the division of radiology in the shinshu-university hospital. The e-mail address for contacting Yasuo Adachi is yadachi@shinshu-u.ac.jp.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES